| Clostridioides difficile ribotype 106: a systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain TJ Carlson, D Blasingame, AJ Gonzales-Luna, F Alnezary, KW Garey Anaerobe 62, 102142, 2020 | 24 | 2020 |
| Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With Clostridioides difficile Infection TJ Carlson, BT Endres, J Le Pham, AJ Gonzales-Luna, FS Alnezary, ... Open forum infectious diseases 7 (1), ofz552, 2020 | 16 | 2020 |
| Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent Clostridium difficile infections: a systematic review … AA Alhifany, AR Almutairi, TA Almangour, AN Shahbar, I Abraham, ... BMJ open 9 (11), e031145, 2019 | 14 | 2019 |
| Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains MS Almutairi, AJ Gonzales-Luna, FS Alnezary, SB Fallatah, MJ Alam, ... Anaerobe 72, 102440, 2021 | 9 | 2021 |
| Corticosteroids Do Not Increase the Likelihood of Primary Clostridioides difficile Infection in the Setting of Broad-Spectrum Antibiotic Use TJ Carlson, AJ Gonzales-Luna, MF Wilcox, SG Theriault, FS Alnezary, ... Open Forum Infectious Diseases 8 (10), ofab419, 2021 | 8 | 2021 |
| Efficacy of clotrimazole for the management of oral candidiasis: A meta-analysis of randomized clinical trials TA Almangour, KS Kaye, M Alessa, K Eljaaly, FS Aleanizy, A Alsharidi, ... Saudi Pharmaceutical Journal: SPJ 29 (4), 315, 2021 | 6 | 2021 |
| Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA TT Tran, NL Cabrera, AJ Gonzales-Luna, TJ Carlson, F Alnezary, ... JAC-Antimicrobial Resistance 5 (1), dlac131, 2023 | 3 | 2023 |
| Development of the invasive candidiasis discharge [I Can discharge] model: a mixed methods analysis J Jo, TT Tran, ND Beyda, D Simmons, JA Hendrickson, MS Almutairi, ... European Journal of Clinical Microbiology & Infectious Diseases 41 (10 …, 2022 | 2 | 2022 |
| Significant Publications on Infectious Diseases Pharmacotherapy in 2020 TA Eubank, N Zaidan, FS Alnezary, C Moc, K Olson, A Zaki, ... Journal of Pharmacy Practice, 08971900211040438, 2021 | 2 | 2021 |
| The appropriateness of proton pump inhibitors usage in non-intensive care unit patients: a retrospective cross sectional study F Alnezary, R Crossman, Y Alatawi, D Lauren, M Mcallister, MA Mahmoud Lat Am J Pharm 38, 230-235, 2019 | 1 | 2019 |
| Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent infections: a systematic review and Bayesian network … AA Alhifany, AR Almutairi, TA Almangour, AN Shahbar, I Abraham, ... BMJ PUBLISHING GROUP, 2019 | | 2019 |
